All Presentations

Satellite Session at SA AIDS: South Africa’s Investment Case: What are the country’s “best buys” for HIV and TB?

HE2RO staff Dr Gesine Meyer-Rath and Calvin Chiu were instrumental in the analysis behind the South African HIV and TB Investment Case for which results have just been finalized. The Investment Case is an analytical exercise by the South African Department of Health, SANAC and UNAIDS to establish the most cost effective mix of interventions against both HIV and TB over the next twenty years. Results for Phase 1 of the Investment Case were discussed in a satellite session, during the 7th South 

Rapid antiretroviral therapy initiation reduces attrition between HIV testing and treatment in Africa

Abstract  Background: Very high rates of patient attrition from HIV care between HIV testing and antiretroviral therapy (ART) initiation have been documented in sub-Saharan Africa. Accelerating the steps required for ART initiation has been proposed to reduce attrition and achieve earlier treatment initiation. Methods: The RapIT study evaluated the effect of immediate ART initiation on ART uptake and retention in a COJ clinic and hospital. Non-pregnant adults receiving a positive HIV test or